Package 70121-1644-1

Brand: decitabine

Generic: decitabine
NDC Package

Package Facts

Identity

Package NDC 70121-1644-1
Digits Only 7012116441
Product NDC 70121-1644
Description

1 VIAL, SINGLE-USE in 1 CARTON (70121-1644-1) / 20 mL in 1 VIAL, SINGLE-USE

Marketing

Marketing Status
Marketed Since 2019-12-01
Brand decitabine
Generic decitabine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "5b9c6cb1-3315-4023-8a3b-9c92596d01f9", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["776B62CQ27"], "rxcui": ["636631"], "spl_set_id": ["40e7ef72-8df5-4adf-a269-4ae1c26eb6f9"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (70121-1644-1)  / 20 mL in 1 VIAL, SINGLE-USE", "package_ndc": "70121-1644-1", "marketing_start_date": "20191201"}], "brand_name": "Decitabine", "product_id": "70121-1644_5b9c6cb1-3315-4023-8a3b-9c92596d01f9", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "70121-1644", "generic_name": "decitabine", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Decitabine", "active_ingredients": [{"name": "DECITABINE", "strength": "50 mg/20mL"}], "application_number": "ANDA206033", "marketing_category": "ANDA", "marketing_start_date": "20191201", "listing_expiration_date": "20261231"}